pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May lead to loss of virologic response and possible resistance.Pero, por otra parte, apuntan que “en España no hay comercializado ningún medicamento de uso humano que contenga pentobarbi